Don't Just Read the News, Understand It.
Published loading...Updated

…And Then the Medicine for a Rare Childhood Disease Suddenly Became 400 Times More Expensive

Summary by Follow the Money - Platform Voor Onderzoeksjournalistiek…
Researchers at Erasmus MC discovered that a group of children with a fatal condition benefit from an old drug that costs next to nothing. A Swedish pharmaceutical company obtained the monopoly and is now marketing the drug for an exorbitant amount.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right

Researchers at Erasmus MC discovered that a group of children with a fatal condition benefit from an old drug that costs next to nothing. A Swedish pharmaceutical company obtained the monopoly and is now marketing the drug for an exorbitant amount.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Follow the Money - Platform voor onderzoeksjournalistiek… broke the news in on Thursday, June 26, 2025.
Sources are mostly out of (0)